Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Glaxosmithkline reported GBP20.7B in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Amgen AMGN:US USD 14.22B 1.47B
AstraZeneca AZN:LN USD 24.86B 1.43B
Bausch Health Companies Inc VRX:CN USD 3.92B 18M
Catalent CTLT:US USD 1.53B 583M
Corcept Therapeutics CORT:US USD 78.86M 6.37M
Drreddys Laboratories RDY:US INR 85.84B 1.46B
Eli Lilly LLY:US USD 16.01B 1.13B
Endo International ENDP:US USD 606.64M 82.98M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Glaxosmithkline GSK:US GBP 20.7B 2.11B
Horizon Pharma HZNP:US USD 884.89M 64.25M
J&J JNJ:US USD 60.37B 4.57B
Novartis NOVN:VX USD 30.55B 1.89B
Pacira PCRX:US USD 98.7M 49.08M
Perrigo PRGO:US USD 1.09B 26.8M
Phibro Animal Health PAHC:US USD 165.31M 2.26M
Prestige Brands PBH:US USD 160.72M 539K
Roche Holding ROG:VX 27.24B 170M
Supernus Pharmaceuticals SUPN:US USD 731.54M 43.59M
Takeda 4502:JP JPY 2.48T 245.13B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 10.41B 1.06B
Zoetis ZTS:US USD 1.92B 1.25B